CW June 2006
Volume 15Issue Number 6 June 2006 ISSN 10593802 Thalidomide Improves Survival in Elderly Multiple Myeloma PatientsA multi-institutional research team in France has show that giving elderly multiple myeloma patients the drug thalidomide in addition to two standard drugs improved survival compared with either the standard therapy alone or a stem cell transplant.
Go to Previous Page Go to Next Page Source & Additional Reading Thierry Facon, Professor of Hematology at the University of Lille, at the American Society of Clinical Oncology. Purchase Downloadable Full-text PDF of Article: $10.00 Subscription is more cost effective than purchasing PDFs on-the-fly. Click here for details. Download Complete Issue CW June 2006Purchase Downloadable Full-text PDF of Complete Issue: $20.00 |
|
Member Login | Home | Offices | Subscribe | Glossary | Cancer Technologies | Contact Us
Adenine Press, 2066 Central Avenue, Schenectady, NY 12304 USA |
Re-initialize IP-based Login |
